1. Traffic control for your CNS

Galvani Bioelectronics. No, it is not Italian club music.  It’s the new company formed by Verily Life Sciences and pharma giant, GSK. Over the next few years they will invest nearly $700M USD to spearhead the bioelectronic medicine field. That’s a lot of money for a device projected to be smaller than a grain of rice. These miniature, implantable devices are designed to attach to individual nerves to first interpret then correct the irregular electrical signals caused by many chronic diseases. We’re not sure which will hurt more, the arthritis that caused you to get it or the shock you’ll feel every time it kicks in. Ok, we have no idea if it shocks you. Or if it hurts. But it probably does.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn